Comment on CMS-2026-1255-0001

Alliance for Patient AccessSupportAdvocacy
Summary: The Alliance for Patient Access (AfPA), a national network of healthcare providers, supports the proposed rule to improve interoperability and electronic prior authorization for drugs. They advocate for further refinements to ensure expedited tracks for urgent care, continuity of care for stable patients, and more transparent, clinician-centered step therapy protocols.
On behalf of the Alliance for Patient Access (AfPA), we are submitting a letter of comment regarding the CMS proposed rule. Please see the attached letter here, thank you.

View on Regulations.gov